Moderna says vaccine works against delta variant as WHO warns of global spread

Good news!

Thank you for posting this. The fact is that there will be variants, just like the flu. Why? Because this is a variant of the influenza we have had for a century. IMHO

Thank you my friend Lt Col Charlie Brown for making us aware that the "coronavirus vaccine developed by U.S. biotech firm Moderna is effective against the highly contagious delta variant,'
I was fully vaccinated with Moderna vaccine and my darling wife had her first does last month.
While it is good news that the Moderna vaccine is effective against the delta variant, and in all likelihood the alpha variant, the gamma variant from Brazil seems to be most contagious
Per CDC there are four strains active right now in USA
B.1.1.7 (Alpha): This variant was first detected in the United States in December 2020. It was initially detected in the United Kingdom.
B.1.351 (Beta): This variant was first detected in the United States at the end of January 2021. It was initially detected in South Africa in December 2020.
P.1 (Gamma): This variant was first detected in the United States in January 2021. P.1 was initially identified in travelers from Brazil, who were tested during routine screening at an airport in Japan, in early January.
B.1.617.2 (Delta): This variant was first detected in the United States in March 2021. It was initially identified in India in December 2020.

Selected Characteristics of SARS-CoV-2 Variants of Interest
B.1.427 (Pango lineageexternal icon)a
Spike Protein Substitutions: L452R, D614G
Name (Nextstrainexternal icon)b: 20C/S:452R
WHO Label: Epsilon
First Identified: United States-(California)

Attributes: ~20% increased transmission 21
Modest decrease in susceptibility to the combination of bamlanivimab and etesevimab; however, the clinical implications of this decrease are not known.7Alternative monoclonal antibody treatments are available.14
Reduced neutralization by convalescent and post-vaccination sera 21
Deescalated from a VOC on June 29, 2021 due to the significant decrease in the proportion of B.1.427 lineage viruses circulating nationally and available data indicating that vaccines and treatments are effective against this variant.

B.1.429 (Pango lineageexternal icon)a
Spike Protein Substitutions: S13I, W152C, L452R, D614G
Name (Nextstrainexternal icon)b: 20C/S:452R
WHO Label: Epsilon
First Identified: United States-(California)
Attributes: ~20% increased transmission 21
Reduced susceptibility to the combination of bamlanivimab and etesevimab; however, the clinical implications of this decrease are not known.7Alternative monoclonal antibody treatments are available.14
Reduced neutralization by convalescent and post-vaccination sera 21.
Deescalated from a VOC on June 29, 2021 due to the significant decrease in the proportion of B.1.429 lineage viruses circulating nationally and available data indicating that vaccines and treatments are effective against this variant.

B.1.525 (Pango lineageexternal icon)a
Spike Protein Substitutions: A67V, 69del, 70del, 144del, E484K, D614G, Q677H, F888L
Name (Nextstrainexternal icon)b: 20A/S:484K
WHO Label: Eta
First Identified: United Kingdom/Nigeria – December 2020
Attributes: Potential reduction in neutralization by some EUA monoclonal antibody treatments 7, 14
Potential reduction in neutralization by convalescent and post-vaccination sera 22

B.1.526 (Pango lineageexternal icon)a
Spike Protein Substitutions: L5F, (D80G*), T95I, (Y144-*), (F157S*), D253G, (L452R*), (S477N*), E484K, D614G, A701V, (T859N*), (D950H*), (Q957R*)
Name (Nextstrainexternal icon)b: 20C/S:484K
WHO Label: Iota
First Identified: United States (New York) – November 2020
BEI Reference Isolatec: NR-55359external icon
Attributes: Reduced susceptibility to the combination of bamlanivimab and etesevimab monoclonal antibody treatment; however, the clinical implications of this are not known.7 Alternative monoclonal antibody treatments are available.14
Reduced neutralization by convalescent and post-vaccination sera 22, 24
B.1.526.1 sublineage has been consolidated with this parent lineage

B.1.617.1 (Pango lineageexternal icon)a
Spike Protein Substitutions: (T95I), G142D, E154K, L452R, E484Q, D614G, P681R, Q1071H
Name (Nextstrainexternal icon)b: 20A/S:154K
WHO Label: Kappa
First Identified: India – December 2020
Attributes: Potential reduction in neutralization by some EUA monoclonal antibody treatments 7, 14
Potential reduction in neutralization by post-vaccination sera 26

B.1.617.3 (Pango lineageexternal icon)a
Spike Protein Substitutions: T19R, G142D, L452R, E484Q, D614G, P681R, D950N
Name (Nextstrainexternal icon)b: 20A
First Identified: India – October 2020
Attributes:
Potential reduction in neutralization by some EUA monoclonal antibody treatments 7, 14
Potential reduction in neutralization by post-vaccination sera 26

P.2 (Pango lineageexternal icon)a
Spike Protein Substitutions: E484K, (F565L*), D614G, V1176F
Name (Nextstrainexternal icon)b: 20J
WHO Label: Zeta
First Identified: Brazil – April 2020
Attributes: Potential reduction in neutralization by some EUA monoclonal antibody treatments 7, 14
Reduced neutralization by post-vaccination sera 22, 23

Moderna’s COVID-19 vaccine shows promise against Delta variant in lab study
https://www.youtube.com/watch?v=8UINnxwABV4

FYI MAJ Ken Landgren Maj Robert Thornton 1LT (Anonymous) Kim Bolen RN CCM ACM COL Mikel J. Burroughs LTC Ken Connolly
Cpl Robert Russell PayneCPT Richard Trione MAJ Dale E. Wilson, Ph.D. Maj Bill Smith, Ph.D. A1C Riley SandersSSgt Clare May
SGT (Join to see)SMSgt Tom BurnsSGT Herbert Bollum
MSgt James Clark-RosaWayne SoaresSGT (Join to see)